Skip to main content
. Author manuscript; available in PMC: 2009 Apr 9.
Published in final edited form as: Neuroscience. 2008 Jan 12;152(4):950–958. doi: 10.1016/j.neuroscience.2008.01.009

Fig. 3.

Fig. 3

Examples of effects of cSCS at 90% of MT on CBF in different treatments. A: Responses of ipsilateral CBF to cSCS at 90% of MT before and after intravenous hexamethonium (10 mg/kg). B: spinal transection at C6-C7 segments. C: intrathecal ibotenic acid (0.3mg/ml, 0.1ml, 20min) on C1-C2 spinal segments. D: bilateral dorsal column (DC) transection at rostral C1 segment. E: spinal transection at rostral C1 segment.